CytoDyn Inc.·4

Nov 20, 12:14 PM ET

Eastwood Craig S. 4

4 · CytoDyn Inc. · Filed Nov 20, 2019

Insider Transaction Report

Form 4
Period: 2019-11-13
Eastwood Craig S.
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2019-11-13+250,000250,000 total
    Exercise: $0.30Exp: 2029-11-13Common Stock (250,000 underlying)
Footnotes (1)
  • [F1]The options will vest in twelve equal monthly installments over the one-year period commencing on December 13, 2019.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION